𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PROLONGED SURVIVAL IN RENAL TRANSPLANT RECIPIENT WITH ADVANCED RENAL CELL CARCINOMA BY EVEROLIMUS AND SORAFENIB

✍ Scribed by Prajej Ruangkanchanasetr; Bundith Kanjanapayak; Kamolwan Jungmeechoke

Book ID
108960884
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
393 KB
Volume
16
Category
Article
ISSN
1320-5358

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Upfront, randomized, phase 2 trial of so
Upfront, randomized, phase 2 trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma : Clinical and biomarker analysis
✍ Eric Jonasch; Paul Corn; Lance C. Pagliaro; Carla L. Warneke; Marcella M. Johnso πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 149 KB

## Abstract ## BACKGROUND: The objective of this study was to independently evaluate the objective response rate of sorafenib and sorafenib plus low‐dose interferon‐alfa 2b (IFN) as frontline therapy in patients with metastatic renal cell carcinoma (mRCC). ## METHODS: Untreated patients with cle